Home » Topics » Regulatory

Regulatory
RSS

Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program

Sep. 8, 2000

Combination approved for second-line treatment of hypertension

Sep. 8, 2000

Phase I trial of TOBI in ventilator-associated pneumonia initiated

Sep. 8, 2000

Bone Care launches Hectorol Injection

Sep. 7, 2000

Flavopiridol, a known antitumor agent, now reported effective in models of vascular injury

Sep. 7, 2000

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Sep. 7, 2000

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Anticonvulsants for cluster headache

Sep. 6, 2000

Topiramate has beneficial effects in transformed migraine

Sep. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...